A period of partial clinical remission (PR) may follow the diagnosis of T1D, i.e., stage III of the disease, and this phase is marked by an increased functionality of the surviving β-cells with attendant endogenous insulin production (7, 8). Here, INS is linked to type 1 diabetes mellitus.